CD4 and neoplasm: Furthermore, expression of PD-1 and 4-1BB on CD4+ and CD8+ T cells and PD-L1 on DCs has been reported in the tumor-draining lymph nodes from patients (36), suggesting that GEN1046 may further boost tumor-specific T-cell activation in tumor-draining lymph nodes.